EICHORCondition: Major Depressive Disorder · Sponsor: Pfizer
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The primary objectives of this study are to: 1) Evaluate the efficacy of CP 601,927 compared to placebo in the augmentation of antidepressant therapy (ADT) in patients with Major Depressive Disorder (MDD) using the Montgomery Asberg Depression Rating Scale (MADRS). 2) Evaluate the safety and tolerability of CP 601,927 in patients with MDD on ADT.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Medically healthy males or females aged 18-65 (inclusive). * Patients must have a primary current diagnosis of MDD without psychotic features. * Patients must be receiving ongoing antidepressant therapy at the time of screening. Duration of the current episode of MDD must be at least 8 weeks prior to enrollment without adequate response to treatment. Exclusion Criteria: * Patients with other psychiatric disorders. * Patients who use tobacco products. * Alcohol or substance abuse or dependence. * Treatment with a monoamine oxidase inhibitor within 10 weeks of enrollment. * Pregnancy or breastfeeding. * Clinically significant abnormalities on laboratory tests, electrocardiogram, or physical or neurologic examination.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Arkansas Psychiatric Clinic Clinical Research Trials, P.A. | Little Rock, Arkansas, United States | — |
| Southwestern Research Incorporated | Beverly Hills, California, United States | — |
| Collaborative Neuroscience Network, Inc. | Garden Grove, California, United States | — |
| Synergy Clinical Research Center | National City, California, United States | — |
| Artemis Institute for Clinical Research | San Diego, California, United States | — |
| Radiant Research, Inc. | Denver, Colorado, United States | — |
| Comprehensive Psychiatric Care | Norwich, Connecticut, United States | — |
| William B. Backus Hospital Satellite Blood Draw | Norwich, Connecticut, United States | — |
| Clinical Neuroscience Solutions, Inc. | Jacksonville, Florida, United States | — |
| Florida Clinical Research Center, LLC | Maitland, Florida, United States | — |
| Clinical Neuroscience Solutions, Inc. | Orlando, Florida, United States | — |
| Comprehensive NeuroScience, Inc. | St. Petersburg, Florida, United States | — |
+ 46 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01098240